VEGF Trap-Eye: Completed Phase II enrollment

Regeneron completed enrollment of 200 patients in the double-blind, active-controlled, international Phase II DA VINCI trial comparing 4 dosages of intravitreal VEGF Trap-Eye vs. laser treatment. Rege...